# John J.P. Kastelein

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-j-p-kastelein/

## Facts

| Field | Value |
| --- | --- |
| Citations | 137,790 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 167 |
| i10-index | 731 |
| Last Known Institution | Korea Pharma (South Korea) |
| OpenAlex ID | https://openalex.org/A5077848934 |
| ORCID iD | https://orcid.org/0000-0003-2018-4532 |
| Works | 1,126 |

## Researcher papers

Showing 12 of 14.

- [Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease](https://scholariq.org/papers/antiinflammatory-therapy-with-canakinumab-for-atherosclerotic-disease/)
- [Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease](https://scholariq.org/papers/large-scale-association-analysis-identifies-13-new-susceptibility-loci-for/)
- [Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol](https://scholariq.org/papers/two-phase-3-trials-of-inclisiran-in-patients-with-elevated-ldl-cholesterol/)
- [Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/effect-of-interleukin-1-inhibition-with-canakinumab-on-incident-lung-cancer-in/)
- [Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia](https://scholariq.org/papers/simvastatin-with-or-without-ezetimibe-in-familial-hypercholesterolemia/)
- [Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk](https://scholariq.org/papers/effect-of-high-dose-omega-3-fatty-acids-vs-corn-oil-on-major-adverse/)
- [Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients](https://scholariq.org/papers/bempedoic-acid-and-cardiovascular-outcomes-in-statin-intolerant-patients/)
- [Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial](https://scholariq.org/papers/relationship-of-c-reactive-protein-reduction-to-cardiovascular-event-reduction/)
- [Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins](https://scholariq.org/papers/association-of-ldl-cholesterol-non-hdl-cholesterol-and-apolipoprotein-b-levels/)
- [Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-statin-therapy-in-older-people-a-meta-analysis-of/)
- [Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events](https://scholariq.org/papers/very-low-levels-of-atherogenic-lipoproteins-and-the-risk-for-cardiovascular/)
- [Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk](https://scholariq.org/papers/carotid-intima-media-thickness-progression-as-surrogate-marker-for/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Cholesterol and Lipid Metabolism](https://scholariq.org/topics/cholesterol-and-lipid-metabolism/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Lipid metabolism and disorders](https://scholariq.org/topics/lipid-metabolism-and-disorders/)

## Researcher university

- [Korea Pharma (South Korea)](https://scholariq.org/institutions/korea-pharma-south-korea/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.